The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer
2012 · BMC Cancer · 32 citations
https://doi.org/10.1186/1471-2407-12-598